Pinealon 20 mg

Pinealon peptide is a synthetic tripeptide bioregulator with the amino acid sequence Glu-Asp-Arg (EDR), developed within the Khavinson school of biogerontology research. It is classified as a pineal-tropic short peptide and is studied as a research compound for examining how short peptides interact with neural cells, modulate cognitive-pathway signaling, and influence age-related shifts in pineal-gland biology. Pinealon is frequently cited alongside Epitalon in pineal-aging research and cognitive-research literature.

At the molecular level, Pinealon is investigated for its ability to engage neural cells and modulate gene expression patterns associated with neurotrophic signaling, cellular-stress adaptation, and neuronal homeostasis. Khavinson-school research has proposed that short bioregulators such as Pinealon penetrate cell and nuclear membranes and bind to specific DNA regions, thereby influencing the transcription of genes linked to neurotrophic factor expression, antioxidant defense, and synaptic-pathway proteins. This signaling profile makes Pinealon a useful model for studying how short peptides regulate neural-cell function under conditions of oxidative load and cellular aging, similar to other Khavinson cortex bioregulators.

Research interest in Pinealon peptide has centered on cellular-stress models, cognitive-pathway research, and age-related neural decline models. Foundational work on the Khavinson family of bioregulators has linked short peptides of this type to normalization of neurotrophic gene expression, restoration of cellular function in aged research models, and improved markers of neural resilience (Khavinson V.K., Anisimov V.N., 2009, Advances in Gerontology). Additional work by Khavinson and Linkova has examined Pinealon in neural-cell research and cognitive-pathway research, supporting its continued investigation as a model compound in pineal and neural-aging studies alongside neurotrophic short peptides like Adamax.

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.

The concept of peptide bioregulation originated in research conducted at the Saint Petersburg Institute of Bioregulation and Gerontology, where Professor Vladimir Khavinson and colleagues identified a family of short tissue-specific peptides capable of modulating gene expression in the tissues from which they were derived. Within this framework, the pineal gland emerged as a particularly active site for short-peptide research, given its role in circadian rhythm regulation and age-related neuroendocrine balance.

Pinealon was characterized as a pineal-tropic tripeptide with the sequence Glu-Asp-Arg (EDR). Laboratory observations have suggested that bioregulators of this class can interact with specific DNA sequences and influence the transcription of genes linked to neurotrophic signaling, antioxidant defense, and synaptic-pathway proteins. Pinealon is frequently studied alongside Epitalon, the tetrapeptide bioregulator that emerged from the same research program.

This positioning at the intersection of peptide chemistry, neural-cell biology, and gerontology has made Pinealon a peptide of continued interest in studies of cognitive-pathway research, pineal-gland aging, and short-peptide gene-expression research.

1. Neural Cell Engagement

Pinealon is investigated for its tissue-selective interaction with neural cells, including neurons and glial populations. Laboratory models indicate that short peptides of this class may enter target cells, where they engage with intracellular structures associated with transcriptional control and neurotrophic signaling.

2. Modulation of Neurotrophic Gene Expression

Khavinson-school research suggests that Pinealon can influence the expression of genes involved in neurotrophic factor synthesis, antioxidant defense, and synaptic-pathway proteins. Through these effects, the peptide is studied as a model compound for transcriptional regulation in neural and pineal-gland biology.

3. Cellular-Stress Adaptation

In research models of oxidative load and cellular stress, Pinealon has been examined for its association with balanced redox markers, reduced apoptosis indicators, and improved neural-cell resilience. These observations support its use in laboratory studies of cellular-stress adaptation and age-related neural decline.

4. Cognitive-Pathway Signaling

Pinealon has been studied within cognitive-pathway research models, where it is examined for its association with markers of learning, memory-related signaling, and behavioral adaptation. Research by Khavinson and Linkova has linked the peptide to cognitive-pathway research and neural-cell function in aged experimental models.

Research Applications

Conclusion

Pinealon is a short tripeptide bioregulator with selective activity in neural-cell and pineal-gland research. Through engagement of neural cells, modulation of neurotrophic gene expression, and contributions to cellular-stress adaptation, it serves as a valuable research compound in studies of cognitive-pathway signaling, age-related neural decline, and Khavinson-school peptide bioregulation.

Research Use Disclaimer

This product is intended for research and laboratory use only. It is designed exclusively for in vitro research purposes. All information provided is for educational and research reference only. This product is not intended for human or animal use. It is not a drug, food, or cosmetic and must not be marketed, labeled, or used as such. Use and handling are restricted to trained and qualified professionals.